Glimceed 1 VMF Tablet is a combination anti-diabetic medicine formulated with Glimepiride 1mg, Metformin Hydrochloride 500mg Sustained Release (SR), and Voglibose 0.2mg. It is used in the treatment and management of Type 2 Diabetes Mellitus in adults when blood sugar levels are not adequately controlled through diet, exercise, or dual-drug therapy alone.
Glimepiride stimulates the pancreas to release more insulin, Metformin helps decrease glucose production in the liver and improves insulin sensitivity, while Voglibose slows carbohydrate absorption in the intestine to reduce post-meal blood sugar spikes. Together, these medicines help provide comprehensive blood sugar management.
The sustained release formulation of Metformin provides prolonged glucose control and improved gastrointestinal tolerability.
✔ Composition:
- Glimepiride 1mg
- Metformin Hydrochloride 500mg SR
- Voglibose 0.2mg
✔ Features:
- Triple-combination anti-diabetic medicine
- Sustained release Metformin formulation
- Helps control fasting and post-meal sugar levels
- Supports insulin sensitivity
- Oral prescription tablet
✔ Uses:
- Type 2 Diabetes Mellitus
- Blood sugar management
- Post-prandial glucose control
- Diabetes treatment support
✔ Benefits:
- Helps maintain healthy blood glucose levels
- Reduces post-meal sugar spikes
- Supports better insulin response
- Helps reduce diabetes-related complications
- Supports long-term diabetes management
✔ Directions for Use:
- Use strictly as directed by physician
- Preferably taken with meals
- Swallow whole with water
- Do not crush or chew SR tablets
⚠️ Safety Information:
- Prescription medicine only
- Monitor blood sugar regularly
- May cause hypoglycemia (low blood sugar)
- Avoid excessive alcohol consumption
- Use cautiously in kidney or liver disorders
- Keep out of reach of children
